Phase II Prospective Trial of Stereotactic Hypofractionated Radiation




About the speaker

Michael Dally, MD

Michael Dally, MD
ICON Cancer Centre, Epworth Hospital, Melbourne, Australia

Melbourne-based Radiation Oncologist with a long interest in stereotactic radiosurgery(SRS).

His current interests include the use of Linac-based SRS for multiple intracranial metastases, AVM’s and Parkinson’s disease.

He is currently chair of ICON stereotactic radiosurgery committee for Brain and Spine indications.

More clinical talks from this speaker

Related Videos

  • Dosimetric Comparisons for Single-Isocenter Techniques

    Dosimetric Comparisons for Single-Isocenter Techniques

    Mark De Ridder, MD, PhD
    Universität Ziekenhuis Brussel, Belgium
    Show video


  • Commissioning and Clinical Experience Utilizing Elements Multiple Brain Mets SRS

    Commissioning and Clinical Experience Utilizing Elements Multiple Brain Mets SRS

    Haisong Liu, PhD
    Thomas Jefferson University Hospital, USA
    Show video


  • Role of SRS and Treatment Response Assessment

    Role of SRS and Treatment Response Assessment

    Roberto Spiegelmann, MD
    Sheba Medical Center, Israel
    Show video


  • Surgery for Brain Metastasis: Does It Still Have A Role?

    Surgery for Brain Metastasis: Does It Still Have A Role?

    Orin Bloch, MD
    Northwestern University, Feinberg School of Medicine, Chicago, USA
    Show video


  • Clinical Experience Utilizing Elements Multiple Brain Mets SRS

    Clinical Experience Utilizing Elements Multiple Brain Mets SRS

    Wenyin Shi, MD
    Thomas Jefferson University, USA
    Show video


  • Clinical Evaluation of Elements Multiple Brain Mets SRS

    Clinical Evaluation of Elements Multiple Brain Mets SRS

    Roberto Spiegelmann, MD
    Sheba Medical Center, Israel
    Show video


  • Role of Neo-Adjuvant SRS with Surgical Resection

    Role of Neo-Adjuvant SRS with Surgical Resection

    Nader Pouratian, MD
    University of California Los Angeles, USA
    Show video


  • The Non-Inferiority of Radiosurgery Alone as Initial Therapy for Patients with more than Five Brain Metastases

    The Non-Inferiority of Radiosurgery Alone as Initial Therapy for Patients with more than Five Brain Metastases

    Masaaki Yamamoto, MD, PhD
    Katsuta Hospital Mito GammaHouse, Japan
    Show video


Interested in watching this clinical talk? Please click on the button “WATCH Video” to enter your contact details and to have access to two additional videos from the member-only Novalis Circle. Your contact information will only be used to contact you about Novalis Video related updates.

WATCH Video

Keep Watching

Thank you for watching! Please enter your contact details below to continue watching and to have access to two additional videos from the member-only Novalis Circle. Your contact information will only be used to contact you about Novalis Circle video related updates.

  • Please read the following notice
    I have read the privacy policy. I agree that my information and data will be collected and stored electronically in order to answer my enquiry. Please note: You can revoke your consent at any time with effect for the future by emailing legal@brainlab.com.

Watch video No Thanks

Already Novalis Circle Member?

Member Login

Register now

Thank you for your interest in our Novalis Circle videos. Full-access to the media library is currently available for Novalis Radiosurgery users only. If you are a customer, please register or login to continue.

Register Now Login